In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies - Concepedia

Concepedia

Publication | Open Access

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

DOI Full Paper Access

60

Citations

33

References

2022

Year

Caterina Ieranò, Dario Righelli, Crescenzo D’Alterio, Maria Napolitano, Luigi Portella, Giuseppina Rea, Federica Auletta, Sara Santagata, Anna Maria Trotta, Giuseppe Guardascione,

Journal for ImmunoTherapy of Cancer

Abstract

In PD-1+ human colon cancer cells, NIVO activates tumor survival pathways and could protect tumor cells from conventional therapies.

References

	Year	Citations

Page 1